和铂医药-B11月11日斥资197.8万港元回购15万股
Group 1 - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, intending to repurchase 150,000 shares at a cost of HKD 1.978 million [1]
Group 1 - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, intending to repurchase 150,000 shares at a cost of HKD 1.978 million [1]